Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Perception of muscular effort in multiple sclerosis.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.
[Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica].
Reliability of Accelerometer Scores for Measuring Sedentary and Physical Activity Behaviors in Persons With Multiple Sclerosis.
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.
Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).
Improving drug delivery technology for treating neurodegenerative diseases.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
DNA Damage, DNA Repair, Aging, and Neurodegeneration.
Early Postnatal Myelin Content Estimate of White Matter via T1w/T2w Ratio.
Multiple sclerosis.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Ultrasonographic diagnosis of demyelinating neuropathy.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.
Minimal supportive treatment in natalizumab-related PML in a MS patient.
[Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis].
Olfactory memory impairment in neurodegenerative diseases.

Pages